Evidence map›Paper›PMID 38178293›Full record

Trial reportThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2024

Exploring HIV disease indicators at MDR-TB treatment initiation in South Africa.

K Geiger, A Patil, A Bergman, C Budhathoki, O Heidari, K Lowensen, N Mthimkhulu, K C McNabb, N N Mmed, J Ngozo and 2 more

Open access · greenAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

K GeigerJohns Hopkins University School of Nursing, Baltimore, MD, USA.
A PatilJohns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
A BergmanJohns Hopkins University School of Nursing, Baltimore, MD, USA.
C BudhathokiJohns Hopkins University School of Nursing, Baltimore, MD, USA.
O HeidariJohns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
K LowensenJohns Hopkins Center for Infectious Disease and Nursing Innovation, Baltimore, MD, USA.
N Mthimkhulu
K C McNabbJohns Hopkins University School of Nursing, Baltimore, MD, USA.
N N MmedNational Department of Health, TB Control and Management, Pretoria, South Africa.
J NgozoKwaZulu Natal Department of Health, Pietermaritzburg, South Africa.
N ReynoldsJohns Hopkins University School of Nursing, Baltimore, MD, USA.
J E FarleyJohns Hopkins University School of Nursing, Baltimore, MD, USA.
Johns Hopkins University · USDepartment of Health · ZA

Funding

NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
NRSA Training CoreTL1TR003100 · NCATS · JOHNS HOPKINS UNIVERSITY · PI SAHA, SOMNATH · 2019 to 2023
$4.5M
A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection OutcomesR01AI104488 · NIAID · JOHNS HOPKINS UNIVERSITY · PI FARLEY, JASON EDWARD · 2014 to 2019
$3.2M
Understanding and Predicting Loss to Follow-up from Multi-Drug Resistant Tuberculosis Treatment in the Setting of High-HIV BurdenF30AI165167 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MCNABB, KATHERINE C · 2021 to 2023
$149k
Exploring the Impact of Illness Identity on Intersectional Stigma Through the Care ContinuumF31NR020588 · NINR · JOHNS HOPKINS UNIVERSITY · PI BERGMAN, ALANNA J · 2022 to 2023
$88k
NCATS NIH HHS KL2 TR002317NCATS NIH HHS TL1 TR003100NIAID NIH HHS F30 AI165167NIAID NIH HHS R01 AI104488NINR NIH HHS F31 NR020588
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-HIV AgentsHIV InfectionsTuberculosisTuberculosis, Multidrug-ResistantAdultCD4 Lymphocyte CountCross-Sectional StudiesFemaleHumansMaleSouth AfricaAnti-HIV Agents

Identifiers

PMID38178293
PMCPMC10915896
OpenAlexW4390610807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.